Singapore, 29 March 2007 – Lonza Group (SWX:LONN) and Bio*One Capital broke ground for their large-scale commercial mammalian cell culture manufacturing facility at Tuas Biomedical Park today. This will be the second large-scale mammalian manufacturing plant in Singapore, and the third one globally that Lonza has built.
